Marker of level of liver injury in cases of hepatitis B is –
**Core Concept**
Liver injury in hepatitis B is characterized by varying degrees of inflammation and necrosis, which can be assessed using specific markers. The level of liver injury is crucial in determining the severity of the disease and guiding treatment decisions. In hepatitis B, liver injury markers are essential for monitoring disease progression and response to therapy.
**Why the Correct Answer is Right**
The correct answer is Alanine Transaminase (ALT). ALT is a liver enzyme that is released into the bloodstream when liver cells are damaged. Elevated levels of ALT indicate liver injury, and its level is directly proportional to the severity of liver damage. In hepatitis B, ALT levels are used to assess the level of liver injury, with higher levels indicating more severe liver damage. The ALT level is also used to monitor the response to antiviral therapy and to assess the risk of developing liver cirrhosis.
**Why Each Wrong Option is Incorrect**
* **Option A:** Aspartate Transaminase (AST) is another liver enzyme that is released into the bloodstream when liver cells are damaged, but it is not as specific to liver injury as ALT. AST levels can also be elevated in other conditions, such as muscle damage.
* **Option B:** Alkaline Phosphatase (ALP) is an enzyme that is involved in bone mineralization and is also found in the liver. Elevated ALP levels can indicate liver disease, but it is not as specific to liver injury as ALT.
* **Option C:** Gamma-Glutamyl Transferase (GGT) is an enzyme that is involved in the regulation of glutathione levels and is found in the liver, kidneys, and other tissues. Elevated GGT levels can indicate liver disease, but it is not as specific to liver injury as ALT.
**Clinical Pearl / High-Yield Fact**
ALT levels can fluctuate significantly in patients with hepatitis B, and a single measurement may not accurately reflect the level of liver injury. Therefore, repeated measurements over time are often necessary to assess the severity of liver damage and response to therapy.
**Correct Answer:** A. Alanine Transaminase.